What is stable pain control? A prospective longitudinal study to assess the clinical value of a personalized pain goal

Abstract

Background:

A universal consensus regarding standardized pain outcomes does not exist. The personalized pain goal has been suggested as a clinically relevant outcome measure.

Aim:

To assess the feasibility of obtaining a personalized pain goal and to compare a clinically based personalized pain goal definition versus a research-based study definition for stable pain.

Design:

Prospective longitudinal descriptive study.

Measures:

The attending physician completed routine assessments, including a personalized pain goal and the Edmonton Classification System for Cancer Pain, and followed patients daily until stable pain control, death, or discharge. Stable pain for cognitively intact patients was defined as pain intensity less than or equal to desired pain intensity goal (personalized pain goal definition) or pain intensity ⩽3 (Edmonton Classification System for Cancer Pain study definition) for three consecutive days with <3 breakthroughs per day.

Setting/participants:

A total of 300 consecutive advanced cancer patients were recruited from two acute care hospitals and a tertiary palliative care unit.

Results:

In all, 231/300 patients (77%) had a pain syndrome; 169/231 (73%) provided a personalized pain goal, with 113/169 (67%) reporting a personalized pain goal ⩽3 (median = 3, range = 0–10). Using the personalized pain goal definition as the gold standard, sensitivity and specificity of the Edmonton Classification System for Cancer Pain definition were 71.3% and 98.5%, respectively. For mild (0–3), moderate (4–6), and severe (7–10) pain, the highest sensitivity was for moderate pain (90.5%), with high specificity across all three categories (95%–100%).

Conclusion:

The personalized pain goal is a feasible outcome measure for cognitively intact patients. The Edmonton Classification System for Cancer Pain definition closely resembles patient-reported personalized pain goals for stable pain and would be appropriate for research purposes. For clinical pain management, it would be important to include the personalized pain goal as standard practice.

Keywords

Cancer pain classification pain management pain measurement palliative care neoplasm metastasis advanced cancer patient-reported outcome measures outcome assessment (health care)pain outcome measures

Get full access to this article

View all access options for this article.

References

Fainsinger

Nekolaichuk

Lawlor

Edmonton Classification System for Cancer Pain (ECS-CP), http://palliative.org/NewPC/_pdfs/tools/Quick%20User%20Guide_OnlineD1-Jan13.pdf (2013, accessed 27 July 2016).

Kaasa

Caraceni

Palliative cancer care research. Palliat Med 2010; 24(3): 259–260.

Knudsen

Aass

Fainsinger

, et al. Classification of pain in cancer patients—a systematic review. Palliat Med 2009; 23(4): 295–308.

Knudsen

Brunelli

Klepstad

, et al. Which domains should be included in a cancer pain classification system? Analyses of longitudinal data. Pain 2012; 153: 696–703.

Nekolaichuk

Fainsinger

Lawlor

Challenges of conducting research on cancer pain classification: how do we make sense of the outcomes?

J Palliat Med 2013; 16(11): 1323–1325.

Mercadante

Gebbia

Fabrizio

, et al. Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer 2011; 47: 713–717.

Cherny

Chang

Frager

, et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995; 76: 1283–1293.

Kaplan

Slywka

Slagle

, et al. A titrated morphine analgesic regimen comparing substance users and non-users with AIDS-related pain. J Pain Symptom Manage 2000; 19: 265–273.

Fainsinger

Nekolaichuk

Lawlor

, et al. A multicentre study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 2005; 29(3): 224–237.

10.

Lowe

Nekolaichuk

Fainsinger

, et al. Should the rate of opioid dose escalation be included as a feature in a cancer pain classification system. J Pain Symptom Manage 2008; 35(1): 51–57.

11.

Fainsinger

Fairchild

Nekolaichuk

, et al. Is pain intensity a predictor of the complexity of cancer pain management? J Clin Oncol 2009; 27(4): 585–590.

12.

Fainsinger

Nekolaichuk

Lawlor

, et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010; 46(16): 2896–2904.

13.

Birnie

McGrath

Chambers

CT.

When does pain matter? Acknowledging the subjectivity of clinical significance. Pain 2012; 153: 2311–2314.

14.

Dalal

Hui

Nguyen

, et al. Achieving of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 2012; 118: 3869–3877.

15.

Hui

Bruera

A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol 2014; 32: 1640–1646.

16.

Watanabe

Nekolaichuk

Beaumont

The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology 2012; 21(9): 977–985.

17.

Dworkin

Turk

Wyrwich

, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9: 105–121.

18.

Zhao

Chang

Cleeland

, et al. Determinants of pain severity changes in ambulatory patients with cancer: an analysis from eastern cooperative oncology group trial E2Z02. J Clin Oncol 2014; 32: 312–319.